Inventor
JUDGE ADAM
CA23 patents
⚠️ This page may combine multiple inventors who share the name “JUDGE ADAM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARBUTUS BIOPHARMA CORP
7 patentsUS12016929B2Jun 25, 2024
Lipid formulations for delivery of therapeutic agents
ARBUTUS BIOPHARMA CORP5 citations86
US11786598B2Oct 17, 2023
Lipid formulations for delivery of therapeutic agents
ARBUTUS BIOPHARMA CORP7 citations86
US11446383B2Sep 20, 2022
Lipid formulations for delivery of therapeutic agents
ARBUTUS BIOPHARMA CORP6 citations86
US11427823B2Aug 30, 2022
Targeted compositions
ARBUTUS BIOPHARMA CORP5 citations82
US11191849B2Dec 7, 2021
Compositions and methods for delivering messenger RNA
ARBUTUS BIOPHARMA CORP10 citations79
US12043833B2Jul 23, 2024
Targeted compositions
ARBUTUS BIOPHARMA CORP1 citations60
US12251470B2Mar 18, 2025
Lipid nanoparticle formulations
ARBUTUS BIOPHARMA CORP0 citations55
MACLACHLAN IAN
6 patentsUS8513403B2Aug 20, 2013
Modified siRNA molecules and uses thereof
MACLACHLAN IAN114 citations99
US8101741B2Jan 24, 2012
Modified siRNA molecules and uses thereof
MACLACHLAN IAN252 citations99
US8188263B2May 29, 2012
Modified siRNA molecules and uses thereof
MACLACHLAN IAN241 citations98
US9006191B2Apr 14, 2015
Silencing of polo-like kinase expression using interfering RNA
MACLACHLAN IAN19 citations92
US8598333B2Dec 3, 2013
SiRNA silencing of genes expressed in cancer
MACLACHLAN IAN27 citations92
US8227443B2Jul 24, 2012
Silencing of CSN5 gene expression using interfering RNA
MACLACHLAN IAN31 citations92
PROTIVA BIOTHERAPEUTICS INC
5 patentsUS9074208B2Jul 7, 2015
Modified siRNA molecules and uses thereof
PROTIVA BIOTHERAPEUTICS INC94 citations99
US7915399B2Mar 29, 2011
Modified siRNA molecules and uses thereof
PROTIVA BIOTHERAPEUTICS INC148 citations98
US7807815B2Oct 5, 2010
Compositions comprising immunostimulatory siRNA molecules and DLinDMA or DLenDMA
PROTIVA BIOTHERAPEUTICS INC68 citations98
US9187748B2Nov 17, 2015
Compositions and methods for silencing ebola virus gene expression
PROTIVA BIOTHERAPEUTICS INC93 citations96
US9878042B2Jan 30, 2018
Lipid formulations for delivery of therapeutic agents to solid tumors
PROTIVA BIOTHERAPEUTICS INC23 citations94